/TOI

Oncology Institute Inc

TOI

$5.13USD↑+5.56%+0.27 today

MARKET CAP

512.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$2

$7

AI Summary

Stalk

Sell NowMedium

TOI is in a Stage 4 decline with a Bearish Pivot Point signal confirming sellers in control. Price has broken below the 9/20 EMAs and is trading near 50-SMA support. Medium-term bias remains bearish while the long-term trend remains up. Short-term execution conditions favor selling into weakness and any failed rebounds into the EMA ridge.

↑Q1 2026 revenue $147 M (+41% YoY); pharmacy segment $87.5 M (+77.6% YoY)
↑FY 2026 revenue guidance $630–650 M underscores sustained growth
↓Negative earnings yield and weak profitability factors question returns

Full analysis →

Buying

1

institutions

Selling

7

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.75 M	25.79 M	+333.16 K	+90.2%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	0.00	0.00	+-2.35 M	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-1.83 M	-100.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	0.00	0.00	+-902.81 K	-100.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	0.00	0.00	+-370.18 K	-100.0%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-131.52 K	-100.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	SELL	0.00	0.00	+-50.00 K	-100.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	0.00	0.00	+-44.52 K	-100.0%	0.00%